Preview Mode Links will not work in preview mode

The Retina Channel Podcast

The Retina Channel is an ophthalmology journal club discussing new scientific articles focused on retina. The target audience are eye care professionals who are interested in the most recent advances in retina.

“Our mission is to facilitate transmission of knowledge from researchers to their target audience.”

  1. All Episodes
  2. E25-RIVAL Study: Ranibizumab vs Aflibercept in T&E for wet AMD- Dr. Mark Gillies

E25-RIVAL Study: Ranibizumab vs Aflibercept in T&E for wet AMD- Dr. Mark Gillies

Apr 22, 2019

Dr. Mark Gillies from Sydney, Australia discusses 2-year results of the RIVAL Study which investigated rates of geographic atrophy and visual acuity changes in patients with wet AMD.

 

Full reference: 

Gillies, M. C., Hunyor, A. P., Arnold, J. J., Guymer, R. H., Wolf, S., Ng, P., . . . McAllister, I. L. (2019). Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial. JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2018.6776